Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
Description5-lipoxygenase activating protein (FLAP; ALOX5AP)
Molecular Target 5-lipoxygenase activating protein (FLAP) (ALOX5AP)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationCoronary artery disease (CAD)
Indication DetailsTreat coronary artery disease (CAD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today